12
Views
76
CrossRef citations to date
0
Altmetric
DNA Dynamics and Chromosome Structure

Establishment of an oriP Replicon Is Dependent upon an Infrequent, Epigenetic Event

&
Pages 4149-4161 | Received 12 Mar 2001, Accepted 09 Apr 2001, Published online: 28 Mar 2023

REFERENCES

  • Adams, A.. 1987. Replication of latent Epstein-Barr virus genomes in Raji cells. J. Virol. 61:1743–1746.
  • Aiyar, A., and B. Sugden. 1998. Fusions between Epstein-Barr viral nuclear antigen-1 of Epstein-Barr virus and the large T-antigen of simian virus 40 replicate their cognate origins. J. Biol. Chem. 273:33073–33081.
  • Aiyar, A., C. Tyree, and B. Sugden. 1998. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J. 17:6394–6403.
  • Alexandru, G., W. Zachariae, A. Schleiffer, and K. Nasmyth. 1999. Sister chromatid separation and chromosome re-duplication are regulated by different mechanisms in response to spindle damage. EMBO J. 18:2707–2721.
  • Ambinder, R. F., W. A. Shah, D. R. Rawlins, G. S. Hayward, and S. D. Hayward. 1990. Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J. Virol. 64:2369–2379.
  • Boddy, M. N., and P. Russell. 1999. DNA replication checkpoint control. Front. Biosci. 4:D841–D848.
  • Clarke, D. J., and J. F. Gimenez-Abian. 2000. Checkpoints controlling mitosis. Bioessays 22:351–363.
  • Dahmann, C., J. F. Diffley, and K. A. Nasmyth. 1995. S-phase-promoting cyclin-dependent kinases prevent re-replication by inhibiting the transition of replication origins to a pre-replicative state. Curr. Biol. 5:1257–1269.
  • Dhar, V., and C. L. Schildkraut. 1991. Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats. Mol. Cell. Biol. 11:6268–6278.
  • Dimitrova, D. S., and D. M. Gilbert. 1998. Regulation of mammalian replication origin usage in Xenopus egg extract. J. Cell Sci. 111:2989–2998.
  • Ekwall, K., T. Olsson, B. M. Turner, G. Cranston, and R. C. Allshire. 1997. Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. Cell 91:1021–1032.
  • Gahn, T. A., and C. L. Schildkraut. 1989. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell 58:527–535.
  • Gilbert, D. M., H. Miyazawa, and M. L. DePamphilis. 1995. Site-specific initiation of DNA replication in Xenopus egg extract requires nuclear structure. Mol. Cell. Biol. 15:2942–2954.
  • Grewal, S. I., M. J. Bonaduce, and A. J. Klar. 1998. Histone deacetylase homologs regulate epigenetic inheritance of transcriptional silencing and chromosome segregation in fission yeast. Genetics 150:563–576.
  • Harrison, S., K. Fisenne, and J. Hearing. 1994. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication. J. Virol. 68:1913–1925.
  • Hayles, J., D. Fisher, A. Woollard, and P. Nurse. 1994. Temporal order of S phase and mitosis in fission yeast is determined by the state of the p34cdc2-mitotic B cyclin complex. Cell 78:813–822.
  • Hirt, B.. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365–369.
  • Imai, S., J. Nishikawa, and K. Takada. 1998. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 72:4371–4378.
  • Kirchmaier, A. L., and B. Sugden. 1997. Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. J. Virol. 71:1766–1775.
  • Kirchmaier, A. L., and B. Sugden. 1995. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus. J. Virol. 69:1280–1283.
  • Kirchmaier, A. L., and B. Sugden. 1998. Rep∗: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus. J. Virol. 72:4657–4666.
  • Knutson, J. C., and D. Yee. 1987. Electroporation: parameters affecting transfer of DNA into mammalian cells. Anal. Biochem. 164:44–52.
  • Koshland, D., J. C. Kent, and L. H. Hartwell. 1985. Genetic analysis of the mitotic transmission of minichromosomes. Cell 40:393–403.
  • Krysan, P. J., S. B. Haase, and M. P. Calos. 1989. Isolation of human sequences that replicate autonomously in human cells. Mol. Cell. Biol. 9:1026–1033.
  • Leight, E. R., and B. Sugden. 2000. EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev. Med. Virol. 10:83–100.
  • Lupton, S., and A. J. Levine. 1985. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol. Cell. Biol. 5:2533–2542.
  • Mackey, D., and B. Sugden. 1999. The linking regions of EBNA1 are essential for its support of replication and transcription. Mol. Cell. Biol. 19:3349–3359.
  • Marechal, V., A. Dehee, B. R. Chikhi, T. Piolot, M. M. Coppey, and J. C. Nicolas. 1999. Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J. Virol. 73:4385–4392.
  • Middleton, T., and B. Sugden. 1994. Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J. Virol. 68:4067–4071.
  • Mitchell, T., and B. Sugden. 1995. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69:2968–2976.
  • Navas, T. A., Z. Zhou, and S. J. Elledge. 1995. DNA polymerase epsilon links the DNA replication machinery to the S phase checkpoint. Cell 80:29–39.
  • Piatti, S., T. Bohm, J. H. Cocker, J. F. Diffley, and K. Nasmyth. 1996. Activation of S-phase-promoting CDKs in late G1 defines a “point of no return” after which Cdc6 synthesis cannot promote DNA replication in yeast. Genes Dev. 10:1516–1531.
  • Rawlins, D. R., G. Milman, S. D. Hayward, and G. S. Hayward. 1985. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42:859–868.
  • Reisman, D., and B. Sugden. 1984. An EBNA-negative, EBV-genome-positive human lymphoblast cell line in which superinfecting EBV DNA is not maintained. Virology 137:113–126.
  • Reisman, D., J. Yates, and B. Sugden. 1985. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 5:1822–1832.
  • Rowles, A., and J. J. Blow. 1997. Chromatin proteins involved in the initiation of DNA replication. Curr. Opin. Genet. Dev. 7:152–157.
  • Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
  • Shirakata, M., and K. Hirai. 1998. Identification of minimal oriP of Epstein-Barr virus required for DNA. Biochemistry (Tokyo) 123:175–181.
  • Shirakata, M., K. I. Imadome, and K. Hirai. 1999. Requirement of replication licensing for the dyad symmetry element-dependent replication of the Epstein-Barr virus oriP minichromosome. Virology 263:42–54.
  • Shire, K., D. F. Ceccarelli, H. T. Avolio, and L. Frappier. 1999. EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J. Virol. 73:2587–2595.
  • Simpson, R. T.. 1990. Nucleosome positioning can affect the function of a cis-acting DNA element in vivo. Nature 343:387–389.
  • Steiner, N. C., and L. Clarke. 1994. A novel epigenetic effect can alter centromere function in fission yeast. Cell 79:865–874.
  • Stevenson, J. B., and D. E. Gottschling. 1999. Telomeric chromatin modulates replication timing near chromosome ends. Genes Dev. 13:146–151.
  • Su, W., T. Middleton, B. Sugden, and H. Echols. 1991. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1. Proc. Natl. Acad. Sci. USA 88:10870–10874.
  • Sugden, B., and E. R. Leight. EBV's plasmid replicon: an enigma in cis and trans. Curr Top Microbiol Immunol., in press.
  • Sugden, B., K. Marsh, and J. Yates. 1985. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol. Cell. Biol. 5:410–413.
  • Sugden, B., and N. Warren. 1988. Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis. Mol. Biol. Med. 5:85–94.
  • Yang, L., S. Maruo, and K. Takada. 2000. CD21-mediated entry and stable infection by Epstein-Barr virus in canine and rat cells. J. Virol. 74:10745–10751.
  • Yates, J., N. Warren, D. Reisman, and B. Sugden. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81:3806–3810.
  • Yates, J. L., S. M. Camiolo, and J. M. Bashaw. 2000. The minimal replicator of Epstein-Barr virus oriP. J. Virol. 74:4512–4522.
  • Yates, J. L., and N. Guan. 1991. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J. Virol. 65:483–488.
  • Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812–815.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.